|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2014
|
Mar. 31, 2013
|
|
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||
| Revenue | $ 31,855 | $ 26,571 |
| Cost of revenue | 15,619 | 13,550 |
| Gross margin | 16,236 | 13,021 |
| Operating expenses: | ||
| Research and development | 6,775 | 6,066 |
| Sales and marketing | 6,301 | 5,605 |
| General and administrative | 3,688 | 2,828 |
| Total operating expenses | 16,764 | 14,499 |
| Loss from operations | (528) | (1,478) |
| Other income (expense): | ||
| Interest, net | (19) | (75) |
| Other income, net | 8 | 26 |
| Total other expense | (11) | (49) |
| Loss before income taxes | (539) | (1,527) |
| Income tax benefit | 0 | 56 |
| Net loss | $ (539) | $ (1,471) |
| Net loss per common share: | ||
| Basic (in dollars per share) | $ (0.02) | $ (0.59) |
| Diluted (in dollars per share) | $ (0.02) | $ (0.59) |
| Weighted-average number of shares: | ||
| Basic (in shares) | 23,117 | 2,502 |
| Diluted (in shares) | 23,117 | 2,502 |